We observed the overexpression of ATP6V1B1 in ovarian cancer tissues and cells, and silencing ATP6V1B1 suppressed the proliferation, migration, and invasion abilities of ovarian cancer cells, while increasing the sensitivity of cells to cisplatin. This evidence concerns the gene ATP6V1B1 and ovarian carcinoma.